NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme

BACKGROUND: The signal transduction pathways of epidermal growth factor receptor and Ras are both important in the growth of glioblastoma multiforme (GBM). We hypothesized that inhibition of both pathways would improve the survival time of patients with recurrent GBM. METHODS: Patients with recurren...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Peereboom, David M., Ahluwalia, Manmeet S., Ye, Xiaobu, Supko, Jeffrey G., Hilderbrand, Sarah L., Phuphanich, Surasak, Nabors, L. Burt, Rosenfeld, Myrna R., Mikkelsen, Tom, Grossman, Stuart A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2013
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3607264/
https://ncbi.nlm.nih.gov/pubmed/23328813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nos322
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados